EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights

Yaonan Song, Haoran Wei, Zhitong Zhou, Huiqing Wang, Weijian Hang, Junfang Wu, Dao Wen Wang

Frontiers of Medicine · 2024-02 · 18 (1) · 31-45

DOI: 10.1007/s11684-024-1055-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers of Medicine, online erschienen am 01.03.2024. Verfasst von Yaonan Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuha…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Gastrointestinal Microbiome, Thrombosis. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phenylacetylglutamine (PAGln) is an amino acid derivate that comes from the amino acid phenylalanine. There are increasing studies showing that the level of PAGln is associated with the risk of different cardiovascular diseases. In this review, we discussed the metabolic pathway of PAGln production and the quantitative measurement methods of PAGln. We summarized the epidemiological evidence to show the role of PAGln in diagnostic and prognostic value in several cardiovascular diseases, such as heart failure, coronary heart disease/atherosclerosis, and cardiac arrhythmia. The underlying mechanism of PAGln is now considered to be related to the thrombotic potential of platelets via adrenergic receptors. Besides, other possible mechanisms such as inflammatory response and oxidative stress could also be induced by PAGln. Moreover, since PAGln is produced across different organs including the intestine, liver, and kidney, the cross-talk among multiple organs focused on the function of this uremic toxic metabolite. Finally, the prognostic value of PAGln compared to the classical biomarker was discussed and we also highlighted important gaps in knowledge and areas requiring future investigation of PAGln in cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesGastrointestinal MicrobiomeThrombosisHumansGlutamine

Stichwörter der Autor:innen

PAGlnbiomarkercardiovascular diseasegut microbiotauremic metabolite

Substanzen

phenylacetylglutamineGlutamine

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan, 430030, China.
  • Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. junfang.wu@tjh.tjmu.edu.cn.
  • Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan, 430030, China. junfang.wu@tjh.tjmu.edu.cn.

Zitieren

APA

Song, Y., Wei, H., Zhou, Z., Wang, H., Hang, W., Wu, J., & Wang, D. W. (2024). Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights. Frontiers of Medicine, 18(1), 31-45. https://doi.org/10.1007/s11684-024-1055-9

Vancouver

Song Y, Wei H, Zhou Z, Wang H, Hang W, Wu J, et al. Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights. Frontiers of Medicine. 2024;18(1):31-45. doi:10.1007/s11684-024-1055-9

BibTeX
@article{Song2024,
  author = {Song, Yaonan and Wei, Haoran and Zhou, Zhitong and Wang, Huiqing and Hang, Weijian and Wu, Junfang and Wang, Dao Wen},
  title = {Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights},
  journal = {Frontiers of Medicine},
  year = {2024},
  volume = {18},
  number = {1},
  pages = {31--45},
  doi = {10.1007/s11684-024-1055-9}
}
Kostenlos starten →